Skip to content

Effect of Melissa Officinalis and lavandula angustifolia in treatment of depression

Effect of Melissa officinallis and Lavandula angustifolia products in treatment of depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014061718126N1
Enrollment
60
Registered
2015-06-04
Start date
2015-05-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder. Depressive episode

Interventions

Intervention 1: Melissa officinalis(each cap 500 mg)Usage: 2 cap every 12 hours for 8 weeks. Intervention 2: Fluoxetin : (each cap 5 mg) Usage: 2 cap every 12 hours for 8 weeks. Intervention 3: Lavand
Treatment - Other
Treatment - Drugs
Melissa officinalis(each cap 500 mg)Usage: 2 cap every 12 hours for 8 weeks
Fluoxetin : (each cap 5 mg) Usage: 2 cap every 12 hours for 8 weeks
Lavandula Angustifolia (each cap 500 mg)Usage: 2 cap every 12 hours for 8 weeks

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18 - 65 years old; DSM-V criteria for major depressive disorder(mild to moderate); signed informed consent. Exclusion criteria: positive history of other psychological disorders; consumption of alcohol or other addictive substances in last 2 weeks; serious medical disease; allergic reaction to medical herbs; positive history of suicidal attempt or suicidal intention; pregnancy; consumption of thyroid disorders drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of depression. Timepoint: Baseline,2 , 4 and 8 weeks after starting the medication. Method of measurement: Hamilton rating scale for depression.

Secondary

MeasureTime frame
Side Effects. Timepoint: 0-2-4-8 weeks. Method of measurement: Clinical interview and physical examination and checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mostafa Araj Khodaei

Shahed University

mostafaa33@gmail.com+98 21 6646 4320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 26, 2026